Format
Sort by
Items per page

Send to

Choose Destination

Links from Books

Items: 1 to 20 of 50

1.

The pain chart.

KEELE KD.

Lancet. 1948 Jul 3;2(6514):6-8. No abstract available.

PMID:
18871952
2.

Healthcare resource and lost labour costs of migraine headache in the US.

Osterhaus JT, Gutterman DL, Plachetka JR.

Pharmacoeconomics. 1992 Jul;2(1):67-76.

PMID:
10146980
3.

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, McQuay HJ.

Control Clin Trials. 1996 Feb;17(1):1-12.

PMID:
8721797
4.

The placebo effect in acute headache management: ketorolac, meperidine, and saline in the emergency department.

Harden RN, Gracely RH, Carter T, Warner G.

Headache. 1996 Jun;36(6):352-6.

PMID:
8707552
5.

Ketorolac vs chlorpromazine in the treatment of acute migraine without aura. A prospective, randomized, double-blind trial.

Shrestha M, Singh R, Moreden J, Hayes JE.

Arch Intern Med. 1996 Aug 12-26;156(15):1725-8.

PMID:
8694672
6.

Intranasal lidocaine for treatment of migraine: a randomized, double-blind, controlled trial.

Maizels M, Scott B, Cohen W, Chen W.

JAMA. 1996 Jul 24-31;276(4):319-21.

PMID:
8656545
7.
8.

A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.

Winner P, Ricalde O, Le Force B, Saper J, Margul B.

Arch Neurol. 1996 Feb;53(2):180-4.

PMID:
8639069
9.

Intravenous chlorpromazine vs intravenous metoclopramide in acute migraine headache.

Cameron JD, Lane PL, Speechley M.

Acad Emerg Med. 1995 Jul;2(7):597-602.

10.

The efficacy of metoclopramide in the treatment of migraine headache.

Ellis GL, Delaney J, DeHart DA, Owens A.

Ann Emerg Med. 1993 Feb;22(2):191-5.

PMID:
8427430
11.

Impact of migraine and tension-type headache on life-style, consulting behaviour, and medication use: a Canadian population survey.

Edmeads J, Findlay H, Tugwell P, Pryse-Phillips W, Nelson RF, Murray TJ.

Can J Neurol Sci. 1993 May;20(2):131-7.

PMID:
8334575
12.

Current emergency treatment of severe migraine headaches.

Klapper JA, Stanton J.

Headache. 1993 Nov-Dec;33(10):560-2.

PMID:
8294195
13.

Concomitant administration of antiemetics is not necessary with intramuscular dihydroergotamine.

Winner P, Dalessio D, Mathew N, Sadowsky C, Turkewitz LJ, Sheftell F, Silberstein SD, Solomon S.

Am J Emerg Med. 1994 Mar;12(2):138-41.

PMID:
8161382
14.

Healthcare resource use and costs associated with migraine in a managed healthcare setting.

Clouse JC, Osterhaus JT.

Ann Pharmacother. 1994 May;28(5):659-64.

PMID:
8069007
15.

Safety and efficacy of rectal prochlorperazine for the treatment of migraine in the emergency department.

Jones EB, Gonzalez ER, Boggs JG, Grillo JA, Elswick RK Jr.

Ann Emerg Med. 1994 Aug;24(2):237-41. Erratum in: Ann Emerg Med 1994 Oct;24(4):618.

PMID:
8037389
16.

Migraine heterogeneity. Disability, pain intensity, and attack frequency and duration.

Stewart WF, Shechter A, Lipton RB.

Neurology. 1994 Jun;44(6 Suppl 4):S24-39. Review.

PMID:
8008223
17.

Migraine prevalence. A review of population-based studies.

Stewart WF, Shechter A, Rasmussen BK.

Neurology. 1994 Jun;44(6 Suppl 4):S17-23. Review.

PMID:
8008222
18.

Zatosetron, a 5-HT3 receptor antagonist in a multicenter trial for acute migraine.

Chappell AS, Bay JM, Botzum GD, Cohen ML.

Neuropharmacology. 1994 Mar-Apr;33(3-4):509-13.

PMID:
7984290
19.
20.

Ketorolac versus meperidine-plus-promethazine treatment of migraine headache: evaluations by patients.

Davis CP, Torre PR, Williams C, Gray C, Barrett K, Krucke G, Peake D, Bass B Jr.

Am J Emerg Med. 1995 Mar;13(2):146-50.

PMID:
7893296

Supplemental Content

Support Center